(Q28142886)

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cadherin cell adhesion receptors as a morphogenetic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Adhesion molecules as determinants of disease: from molecular biology to surgical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin mediated adhesion system in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Structural basis of cell-cell adhesion by cadherins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

The uvomorulin-anchorage protein alpha catenin is a vinculin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

A causal role for E-cadherin in the transition from adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cadherin and catenin biology represent a global mechanism for epithelial cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Roles of Axin in the Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Functional interaction of beta-catenin with the transcription factor LEF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

TCF/LEF factor earn their wings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Uncoupling cadherin-based adhesion from wingless signalling in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Nuclear localization of beta-catenin by interaction with transcription factor LEF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

A common human skin tumour is caused by activating mutations in beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cadherin-catenin expression in primary colorectal cancer: a survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Mutations of the human E-cadherin (CDH1) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin gene mutations in signet ring cell carcinoma of the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Relationship between ERBB2 and E-cadherin expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Loss of E-cadherin expression in early gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Characterization of soluble E-cadherin as a disease marker in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

The molecular histology of neoplasia: the role of the cadherin/catenin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Antiproliferative activity of interferon alpha and retinoic acid in SiHa carcinoma cells: the role of cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of beta-catenin in metastatic human renal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Changes in gene structure and regulation of E-cadherin during epithelial development, differentiation, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X

Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2000.01513.X